Clindamycin 1% / Tretinoin 0.025%
Is It Right for You?
A complete guide to Clindamycin 1% / Tretinoin 0.025% — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Clindamycin 1% / Tretinoin 0.025%?
Clindamycin 1%/Tretinoin 0.025% is a fixed-dose combination topical preparation containing two complementary anti-acne agents: clindamycin phosphate, a topical antibiotic, and tretinoin (all-trans retinoic acid), a topical retinoid. The combination is designed to simultaneously address the two principal pathogenic mechanisms of acne vulgaris — bacterial colonisation and abnormal follicular keratinisation — providing superior efficacy to either agent used alone.
This preparation is available in gel formulations and is applied once daily at night to acne-affected skin. The combination approach also helps mitigate the emergence of antibiotic resistance that can occur with topical clindamycin monotherapy, as the retinoid component enhances follicular penetration of clindamycin and independently reduces comedone formation.
Clindamycin 1%/Tretinoin 0.025% is a prescription-only medication in the UK. A licensed clinician must assess your acne severity, skin type, and suitability before prescribing.
What Conditions Is Clindamycin 1%/Tretinoin 0.025% Used For?
Acne vulgaris (moderate to severe) — inflammatory acne, comedonal acne, and mixed-pattern acne in adults and adolescents (aged 12 and over)
inflammatory acne, comedonal acne, and mixed-pattern acne in adults and adolescents (aged 12 and over)
Significant improvement in acne typically requires eight to twelve weeks of consistent daily use. The combination does not provide a permanent cure; maintenance therapy and ongoing skincare optimisation are typically required to sustain results.
How Does Clindamycin 1%/Tretinoin 0.025% Work?
Clindamycin (antibiotic component) — clindamycin phosphate penetrates the pilosebaceous unit and inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of Cutibacterium acnes (formerly Propionibacterium acnes), the anaerobic bacterium that colonises sebaceous follicles and drives the inflammatory cascade in acne. By reducing C. acnes populations, clindamycin reduces the production of pro-inflammatory lipases and free fatty acids, decreasing the inflammatory response within follicles.
Tretinoin (retinoid component) — tretinoin is a first-generation retinoid that acts on retinoic acid receptors (RARs) in follicular keratinocytes, normalising the abnormal desquamation and cohesion of follicular epithelial cells that leads to microcomedone formation. By promoting normal keratinisation, tretinoin prevents the formation of new comedones, reduces existing comedones, and enhances the penetration of clindamycin into the follicle. Tretinoin is comedolytic, anti-inflammatory, and promotes skin cell turnover.
Together, these mechanisms address all four major pathogenic factors in acne: excess sebum, follicular hyperkeratinisation, C. acnes colonisation, and inflammation.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Apply at night only. Tretinoin significantly increases photosensitivity; nighttime application minimises UV exposure to treated skin.
Cleanse the skin gently with a mild, non-irritating cleanser and allow the skin to dry completely for 20–30 minutes before applying the gel. Applying to damp skin increases irritation.
Use a pea-sized amount spread thinly across the entire acne-affected area, not just individual spots. This comedolytic approach treats existing lesions and prevents new ones forming.
Apply a broad-spectrum SPF 30 or higher sunscreen every morning. Tretinoin substantially reduces the skin's natural UV protection; daily photoprotection is essential to prevent hyperpigmentation and burning.
Moisturise. Daily use of a non-comedogenic moisturiser reduces the dryness and irritation associated with retinoid use, particularly during the first four to six weeks.
Expect a purge period. During the first two to six weeks, acne may appear to worsen temporarily as tretinoin accelerates follicular cell turnover, bringing developing microcomedones to the surface. Persisting through this initial phase is important.
Side Effects of Clindamycin 1%/Tretinoin 0.025%
Most side effects are mild and resolve on their own. Serious side effects are rare but require immediate medical attention.
- Dryness, peeling, and flaking — very common, particularly in the first four to six weeks; usually resolves with continued use and moisturisation
- Erythema (redness) and irritation at the application site
- Stinging or burning sensation on application
- Skin photosensitivity — increased susceptibility to sunburn
- Initial acne flare (the 'retinoid purge') during weeks two to six
- Severe skin irritation or dermatitis — marked swelling, blistering, or skin breakdown; discontinue and seek review
- Pseudomembranous colitis — rare with topical clindamycin but reported; severe diarrhoea during or after treatment requires urgent assessment
- Severe allergic contact dermatitis
- Hyperpigmentation or hypopigmentation — particularly in darker skin tones; more likely if sun protection is inadequate
Tretinoin substantially increases skin sensitivity to ultraviolet radiation. Daily use of a broad-spectrum SPF 30 (or higher) sunscreen is not optional — it is a mandatory component of treatment.
Drug Interactions
Always disclose all prescription drugs, over-the-counter medicines, vitamins, and supplements to your clinician or pharmacist before starting Clindamycin 1%/Tretinoin 0.025%
concurrent use significantly increases skin irritation; avoid using multiple active topical agents simultaneously unless specifically directed by your clinician.
not relevant for topical application at standard doses given low systemic absorption.
avoid application of alcohol-containing toners or astringents over treated skin; markedly increases irritation.
Important Warnings
Tretinoin, like all retinoids, is teratogenic. Although systemic absorption from topical tretinoin at 0.025% is low, it is contraindicated during pregnancy and in women who are planning a pregnancy. Effective contraception is required during treatment.
Daily SPF 30+ sunscreen must be applied every morning during treatment. Inadequate photoprotection risks significant sunburn, worsened post-inflammatory hyperpigmentation, and premature skin ageing.
Topical clindamycin monotherapy is associated with the development of C. acnes resistance. The combination with tretinoin helps mitigate resistance development, but clindamycin-containing preparations should not be used indefinitely. Treatment duration should be reviewed regularly, and combination with benzoyl peroxide (under clinician guidance) further reduces resistance risk.
Avoid contact with eyes, nostrils, and the corners of the mouth. If contact occurs, rinse thoroughly with water.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Clindamycin 1%/Tretinoin 0.025% FAQs
Visible improvement in acne typically begins at six to eight weeks, with more substantial results at twelve weeks. Full benefit may require four to six months of consistent use. Early worsening during weeks two to six is normal and expected.
Dryness and peeling are expected side effects, particularly in the first four to six weeks. Rather than stopping, try reducing application to every other night temporarily and using a generous non-comedogenic moisturiser. Gradually increase back to nightly use as tolerance develops. Only discontinue if irritation is severe.
No. Tretinoin is photosensitising and is deactivated by UV light. Daytime application increases the risk of sunburn and reduces efficacy. Always apply at night.
Tretinoin thins the stratum corneum and reduces the skin's natural UV protection, making treated skin significantly more susceptible to sunburn and post-inflammatory hyperpigmentation. Daily SPF 30 or higher is essential and non-negotiable during treatment.
Yes, but careful management of photosensitivity is particularly important. Post-inflammatory hyperpigmentation is more common in darker skin tones, making daily sun protection even more critical. If irritation causes significant erythema, reducing the frequency of application can help minimise hyperpigmentation risk.